Clinical Trial Update: Aprepitant Without Steroid in Preventing Chemotherapy-induced Nausea and Vomiting in Patients With Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial investigating aprepitant without steroid for preventing chemotherapy-induced nausea and vomiting in colorectal cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Colorectal Cancer

Drugs mentioned

• Aprepitant (aprepitant)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Chemotherapy-induced Nausea and Vomiting, Colorectal Cancer | Phase 3 | Status: COMPLETED